NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Renasant Bio

Renasant Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.renasantbio.com/

Last Round

Seed

Jul 10, 2025

Total Funding Raised

$54.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to target the underlying biology of autosomal dominant polycystic kidney disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

ADPKDautosomal dominant polycystic kidney diseasesmall molecule therapybiopharmaceuticaldrug discoveryprecision medicinekidney disease treatmentpolycystinbiotech startupprotein dysfunctiontherapeutic pipelinepreclinical researchorphan drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renasant Bio Comps

Public and private peers based on sector, stage, and business model.

Renasant Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Renasant Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 10, 2025

Renasant Bio Investors

Notable investors and investment history

Renasant Bio investors
InvestorRounds
OrbiMedSeed
5AM VenturesSeed
QimingSeed
Atlas VentureSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 540% MoM.

  • Dec 12, 2025

    Based out of the Bakar Labs incubator in Berkeley, CA.

Renasant Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Renasant Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Renasant Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range33
Year Founded2025
Last FundingJul 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.